These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22247875)

  • 1. Anticounterfeit packaging technologies.
    Shah RY; Prajapati PN; Agrawal YK
    J Adv Pharm Technol Res; 2010 Oct; 1(4):368-73. PubMed ID: 22247875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing anti-counterfeiting measures: The role of smart packaging.
    Soon JM; Manning L
    Food Res Int; 2019 Sep; 123():135-143. PubMed ID: 31284961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-counterfeit technologies: a pharmaceutical industry perspective.
    Bansal D; Malla S; Gudala K; Tiwari P
    Sci Pharm; 2013; 81(1):1-13. PubMed ID: 23641326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point-of-Care Anti-Counterfeit Medicines Technologies: Awareness and Utilization among Medical Practitioners in Eastern Nigeria.
    Iloh GU; Akodu BA; Emeka EA; Obi IV
    West Afr J Med; 2021 Nov; Vol. 38(11):1029-1035. PubMed ID: 34918894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticounterfeit protection of pharmaceutical products with spatial mapping of X-ray-detectable barcodes and logos.
    Musumeci D; Hu C; Ward MD
    Anal Chem; 2011 Oct; 83(19):7444-50. PubMed ID: 21877684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Materials and Technologies to Combat Counterfeiting of Pharmaceuticals: Current and Future Problem Tackling.
    Zhang H; Hua D; Huang C; Samal SK; Xiong R; Sauvage F; Braeckmans K; Remaut K; De Smedt SC
    Adv Mater; 2020 Mar; 32(11):e1905486. PubMed ID: 32009266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The silent development of counterfeit medications in developing countries - A systematic review of detection technologies.
    Bolla AS; Patel AR; Priefer R
    Int J Pharm; 2020 Sep; 587():119702. PubMed ID: 32736015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serialized holography for brand protection and authentication.
    Vather D; Naydenova I; Cody D; Zawadzka M; Martin S; Mihaylova E; Curran S; Duffy P; Portillo J; Connell D; McDonnell S; Toal V
    Appl Opt; 2018 Aug; 57(22):E131-E137. PubMed ID: 30117909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Challenge of Counterfeit Drugs: A Comprehensive Review on Prevalence, Detection and Preventive Measures.
    Kumar B; Baldi A
    Curr Drug Saf; 2016; 11(2):112-20. PubMed ID: 26463250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Counterfeit pharmaceuticals: current status and future projections.
    Wertheimer AI; Chaney NM; Santella T
    J Am Pharm Assoc (2003); 2003; 43(6):710-7; quiz 717-8. PubMed ID: 14717268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Counterfeit pharmaceuticals in Peru].
    Exebio LE; Rodríguez J; Sayritupac F
    Rev Panam Salud Publica; 2010 Feb; 27(2):138-43. PubMed ID: 20339618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceptions and practices of pharmaceutical wholesalers surrounding counterfeit medicines in a developing country: a baseline survey.
    Khan MH; Akazawa M; Dararath E; Kiet HB; Sovannarith T; Nivanna N; Yoshida N; Kimura K
    BMC Health Serv Res; 2011 Nov; 11():306. PubMed ID: 22074046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanocatalyst-Enabled Physically Unclonable Functions as Smart Anticounterfeiting Tags with AI-Aided Smartphone Authentication.
    Moglianetti M; Pedone D; Morerio P; Scarsi A; Donati P; Bustreo M; Del Bue A; Pompa PP
    ACS Appl Mater Interfaces; 2022 Jun; 14(22):25898-25906. PubMed ID: 35612325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of radio frequency identification-related radiation on in vitro biologics.
    Uysal I; Hohberger C; Rasmussen RS; Ulrich DA; Emond JP; Gutierrez A
    PDA J Pharm Sci Technol; 2012; 66(4):333-45. PubMed ID: 22767882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Microtaggant Technology for Ensuring Traceability of Pharmaceutical Formulations: Potential for Anti-counterfeiting Measures, Distribution and Medication Management].
    Yasunaga T; Fukuoka T; Yamaguchi A; Ogawa N; Yamamoto H
    Yakugaku Zasshi; 2022; 142(11):1255-1265. PubMed ID: 36328452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caveat oncologist: clinical findings and consequences of distributing counterfeit erythropoietin in the United States.
    Qureshi ZP; Norris L; Sartor O; McKoy JM; Armstrong J; Raisch DW; Garg V; Stafkey-Mailey D; Bennett CL
    J Oncol Pract; 2012 Mar; 8(2):84-90. PubMed ID: 23077434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Counterfeit medicines: a growing threat].
    Barbereau S
    Med Trop (Mars); 2006 Dec; 66(6):529-32. PubMed ID: 17286014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor-Quality and Counterfeit Drugs: A Systematic Assessment of Prevalence and Risks Based on Data Published From 2007 to 2016.
    Koczwara A; Dressman J
    J Pharm Sci; 2017 Oct; 106(10):2921-2929. PubMed ID: 28549909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.